Iga Swiatek, the French Open champion, has been handed a one-month suspension after testing positive for the banned substance trimetazidine (TMZ) in August 2024, the International Tennis Integrity Agency (ITIA) announced on Thursday. The 23-year-old Polish tennis star had provided an out-of-competition sample, which revealed the presence of the substance.
However, the ITIA accepted Swiatek's explanation that the positive test resulted from contamination of a non-prescription melatonin supplement she had been using to address sleep and jet lag issues. The agency determined that the violation was not intentional, and they concluded that Swiatek's fault was minimal, placing her on the lowest end of the spectrum for "No Significant Fault or Negligence."
Swiatek, who has won five Grand Slam titles, acknowledged the suspension, which is set to run for a month. She had already been provisionally suspended from September 22 to October 4, which caused her to miss three tournaments, with those days counting toward her penalty. As a result, she has eight days left on the suspension.
In addition to the suspension, Swiatek will forfeit the prize money she earned from the Cincinnati Open, where she was defeated by world number one Aryna Sabalenka in the final, just after the doping test.
ADD A COMMENT :